Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.26 +0.44 (+11.65%)
As of: Oct 21, 2026 · 3:45 PM EDT

Adial Pharmaceuticals (ADIL) Operating Leases (2021 - 2023)

Updated

Adial Pharmaceuticals' Operating Leases was $135,045 in Q1 2023, down 30.3% from $193,797 a year earlier and down 10.3% from the prior quarter.

Analysis

Adial Pharmaceuticals (ADIL) Operating Leases (2021 - 2023) Analysis & Trends

At the end of FY2022, Operating Leases at Adial Pharmaceuticals came in at $150,547, down 27.4% from FY2021.

  • In earlier years, Operating Leases was $207,375 in FY2021.
  • Per Business Quant data, ADIL's Operating Leases in the three quarters before Q1 2023 was $150,547 (Q4 2022), $165,288 (Q3 2022) and $179,702 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Adial Pharmaceuticals 19.71 Mn -24.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 135,045.00
Dec 31, 2022 150,547.00
Sep 30, 2022 165,288.00
Jun 30, 2022 179,702.00
Mar 31, 2022 193,797.00
Dec 31, 2021 207,375.00
API Access

Adial Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ADIL&period=max&api_key=YOUR_API_KEY